Keymed Biosciences
China - ChengduBiotechnology
Focus: Keymed Biosciences is a biotechnology company headquartered in Chengdu, China, specializing in monoclonal antibodies, antibody-drug conjugates (ADCs), and bispecific antibodies.
Profile data last refreshed 2d ago · AI intelligence enriched 2w ago
Open Jobs
0
About Keymed Biosciences
AI assessmentNot HiringNo open roles listed right now. Follow Keymed Biosciences to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
50 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Clinical Trials (1)
NCT06745687BCMA/CD3 BsAb in the Treatment of High-risk Smoldering Multiple Myeloma
N/AHelp build intelligence for Keymed Biosciences
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.